Aclarion, Inc. Warrant
ACONW
ACONW: Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
moreShow ACONW Financials
Recent trades of ACONW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACONW's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method Apr. 25, 2023
-
Patent Title: Magnetic resonance spectroscopy system and method for diagnosing pain or infection associated with propionic acid Jan. 31, 2023
Federal grants, loans, and purchases
Followers on ACONW's company Twitter account
Number of mentions of ACONW in WallStreetBets Daily Discussion
Recent insights relating to ACONW
Recent picks made for ACONW stock on CNBC
ETFs with the largest estimated holdings in ACONW
Flights by private jets registered to ACONW